Crystallography Open Database
Search results
Result: there are 13743 entries in the selection
Switch to the old layout of the pageDownload all results as: list of COD numbers | list of CIF URLs | data in CSV format
We are unable to provide that many records as a single archive.
You can instead download the entire COD archive as a single .zip, .tgz or .txz archive.
Searching journal of publication like 'Crystal Growth & Design'
COD ID  |
Links | Formula  |
Space group |
Cell parameters | Cell volume |
Bibliography |
|---|---|---|---|---|---|---|
| 2000018 | CIF | C124 H120 Ag4 F12 N4 O12 S16 | P -1 | 10.1922; 14.2843; 23.164 99.197; 93.272; 102.595 | 3234.12 | Chen, Banglin; Lee, Stephen; Venkataraman, D.; DiSalvo, Francis J.; Lobkovsky, Emil; Nakayama, Miki Packing Principles of Thioether Derivatives of Triarylamine Silver Salts Crystal Growth & Design, 2002, 2, 101-105 |
| 2000019 | CIF | C33 H45 Ag Cl N O7 S3 | P -1 | 11.033; 12.524; 13.345 70.404; 87.048; 79.495 | 1707.96 | Chen, Banglin; Lee, Stephen; Venkataraman, D.; DiSalvo, Francis J.; Lobkovsky, Emil; Nakayama, Miki Packing Principles of Thioether Derivatives of Triarylamine Silver Salts Crystal Growth & Design, 2002, 2, 101-105 |
| 2000020 | CIF | ? | P -1 | 15.7848; 15.8557; 19.2559 96.079; 105.808; 118.42 | 3917.05 | Chen, Banglin; Lee, Stephen; Venkataraman, D.; DiSalvo, Francis J.; Lobkovsky, Emil; Nakayama, Miki Packing Principles of Thioether Derivatives of Triarylamine Silver Salts Crystal Growth & Design, 2002, 2, 101-105 |
| 3000438 | CIF | C19 H22 N4 O4 S | P 1 21 1 | 10.914; 8.223; 10.386 90; 87.44; 90 | 931.17 | Gogoi, Diptajyoti; Sasaki, Toshiyuki; Nakane, Takanori; Kawamoto, Akihiro; Hojo, Hironobu; Kurisu, Genji; Thakuria, Ranjit Structure Elucidation of Olanzapine Molecular Salts by Combining Mechanochemistry and Micro-Electron Diffraction Crystal Growth & Design, 2023, 23, 5821-5826 |
| 3000439 | CIF | C22 H30 N4 O5 S | P -1 | 8.3239; 9.8354; 14.1883 78.613; 80.88; 87.127 | 1124.11 | Gogoi, Diptajyoti; Sasaki, Toshiyuki; Nakane, Takanori; Kawamoto, Akihiro; Hojo, Hironobu; Kurisu, Genji; Thakuria, Ranjit Structure Elucidation of Olanzapine Molecular Salts by Combining Mechanochemistry and Micro-Electron Diffraction Crystal Growth & Design, 2023, 23, 5821-5826 |
| 3000440 | CIF | C23 H29 N5 O4 S | P 1 21/c 1 | 11.718; 14.498; 14.742 90; 106.84; 90 | 2397.08 | Gogoi, Diptajyoti; Sasaki, Toshiyuki; Nakane, Takanori; Kawamoto, Akihiro; Hojo, Hironobu; Kurisu, Genji; Thakuria, Ranjit Structure Elucidation of Olanzapine Molecular Salts by Combining Mechanochemistry and Micro-Electron Diffraction Crystal Growth & Design, 2023, 23, 5821-5826 |
| 3000441 | CIF | C12 H10 N2 O S | P b c n | 10.815; 12.611; 16.549 90; 90; 90 | 2257.08 | Gogoi, Diptajyoti; Sasaki, Toshiyuki; Nakane, Takanori; Kawamoto, Akihiro; Hojo, Hironobu; Kurisu, Genji; Thakuria, Ranjit Structure Elucidation of Olanzapine Molecular Salts by Combining Mechanochemistry and Micro-Electron Diffraction Crystal Growth & Design, 2023, 23, 5821-5826 |
| 3000442 | CIF | C13 H26 N2 O9 | P -1 | 6.605; 8.935; 15.061 104.04; 97.6; 97.5 | 842.398 | Gogoi, Diptajyoti; Sasaki, Toshiyuki; Nakane, Takanori; Kawamoto, Akihiro; Hojo, Hironobu; Kurisu, Genji; Thakuria, Ranjit Structure Elucidation of Olanzapine Molecular Salts by Combining Mechanochemistry and Micro-Electron Diffraction Crystal Growth & Design, 2023, 23, 5821-5826 |
| 4500000 | CIF | C24 H18 N2 O7 | C 1 2/c 1 | 32.531; 5.2697; 24.159 90; 98.191; 90 | 4099.3 | Scott G. Fleischman; Srinivasan S. Kuduva; Jennifer A. McMahon; Brian Moulton; Rosa D. Bailey Walsh; Naír Rodríguez-Hornedo; Michael J. Zaworotko Crystal Engineering of the Composition of Pharmaceutical Phases: Multiple-Component Crystalline Solids Involving Carbamazepine Crystal Growth & Design, 2003, 3, 909-919 |
| 4500001 | CIF | C47 H40 N6 O16 | C 1 2/c 1 | 34.355; 5.3795; 23.654 90; 93.952; 90 | 4361.2 | Scott G. Fleischman; Srinivasan S. Kuduva; Jennifer A. McMahon; Brian Moulton; Rosa D. Bailey Walsh; Naír Rodríguez-Hornedo; Michael J. Zaworotko Crystal Engineering of the Composition of Pharmaceutical Phases: Multiple-Component Crystalline Solids Involving Carbamazepine Crystal Growth & Design, 2003, 3, 909-919 |
| 4500002 | CIF | C16 H14 N2 O3 | P 1 21/c 1 | 5.2031; 14.741; 17.882 90; 98.132; 90 | 1357.7 | Scott G. Fleischman; Srinivasan S. Kuduva; Jennifer A. McMahon; Brian Moulton; Rosa D. Bailey Walsh; Naír Rodríguez-Hornedo; Michael J. Zaworotko Crystal Engineering of the Composition of Pharmaceutical Phases: Multiple-Component Crystalline Solids Involving Carbamazepine Crystal Growth & Design, 2003, 3, 909-919 |
| 4500003 | CIF | C18 H18 N2 O2 | P -1 | 7.3985; 8.9054; 11.873 95.809; 93.401; 101.362 | 760.5 | Scott G. Fleischman; Srinivasan S. Kuduva; Jennifer A. McMahon; Brian Moulton; Rosa D. Bailey Walsh; Naír Rodríguez-Hornedo; Michael J. Zaworotko Crystal Engineering of the Composition of Pharmaceutical Phases: Multiple-Component Crystalline Solids Involving Carbamazepine Crystal Growth & Design, 2003, 3, 909-919 |
| 4500004 | CIF | C17 H16 N2 O3 | P 1 21/c 1 | 5.1206; 15.7136; 18.4986 90; 96.546; 90 | 1478.8 | Scott G. Fleischman; Srinivasan S. Kuduva; Jennifer A. McMahon; Brian Moulton; Rosa D. Bailey Walsh; Naír Rodríguez-Hornedo; Michael J. Zaworotko Crystal Engineering of the Composition of Pharmaceutical Phases: Multiple-Component Crystalline Solids Involving Carbamazepine Crystal Growth & Design, 2003, 3, 909-919 |
| 4500005 | CIF | C36 H28 N4 O4 | P 1 21/c 1 | 10.3335; 27.611; 4.996 90; 102.275; 90 | 1392.9 | Scott G. Fleischman; Srinivasan S. Kuduva; Jennifer A. McMahon; Brian Moulton; Rosa D. Bailey Walsh; Naír Rodríguez-Hornedo; Michael J. Zaworotko Crystal Engineering of the Composition of Pharmaceutical Phases: Multiple-Component Crystalline Solids Involving Carbamazepine Crystal Growth & Design, 2003, 3, 909-919 |
| 4500006 | CIF | C44 H40 N4 O10 | C 1 2/c 1 | 18.388; 12.682; 16.429 90; 100.491; 90 | 3767.1 | Scott G. Fleischman; Srinivasan S. Kuduva; Jennifer A. McMahon; Brian Moulton; Rosa D. Bailey Walsh; Naír Rodríguez-Hornedo; Michael J. Zaworotko Crystal Engineering of the Composition of Pharmaceutical Phases: Multiple-Component Crystalline Solids Involving Carbamazepine Crystal Growth & Design, 2003, 3, 909-919 |
| 4500007 | CIF | C19 H20 N2 O3 | P -1 | 9.1567; 10.1745; 10.5116 72.85; 70.288; 67.269 | 834.91 | Scott G. Fleischman; Srinivasan S. Kuduva; Jennifer A. McMahon; Brian Moulton; Rosa D. Bailey Walsh; Naír Rodríguez-Hornedo; Michael J. Zaworotko Crystal Engineering of the Composition of Pharmaceutical Phases: Multiple-Component Crystalline Solids Involving Carbamazepine Crystal Growth & Design, 2003, 3, 909-919 |
| 4500008 | CIF | C16 H15 N3 O2 | P -1 | 5.1077; 16.057; 17.752 73.711; 89.35; 88.636 | 1397.1 | Scott G. Fleischman; Srinivasan S. Kuduva; Jennifer A. McMahon; Brian Moulton; Rosa D. Bailey Walsh; Naír Rodríguez-Hornedo; Michael J. Zaworotko Crystal Engineering of the Composition of Pharmaceutical Phases: Multiple-Component Crystalline Solids Involving Carbamazepine Crystal Growth & Design, 2003, 3, 909-919 |
| 4500009 | CIF | C34 H36 N4 O4 S2 | P -1 | 7.3254; 8.889; 12.208 94.84; 94.926; 100.048 | 775.8 | Scott G. Fleischman; Srinivasan S. Kuduva; Jennifer A. McMahon; Brian Moulton; Rosa D. Bailey Walsh; Naír Rodríguez-Hornedo; Michael J. Zaworotko Crystal Engineering of the Composition of Pharmaceutical Phases: Multiple-Component Crystalline Solids Involving Carbamazepine Crystal Growth & Design, 2003, 3, 909-919 |
| 4500010 | CIF | C21 H18 N4 O2 | P 1 21/n 1 | 5.0961; 17.595; 19.647 90; 90.917; 90 | 1761.4 | Scott G. Fleischman; Srinivasan S. Kuduva; Jennifer A. McMahon; Brian Moulton; Rosa D. Bailey Walsh; Naír Rodríguez-Hornedo; Michael J. Zaworotko Crystal Engineering of the Composition of Pharmaceutical Phases: Multiple-Component Crystalline Solids Involving Carbamazepine Crystal Growth & Design, 2003, 3, 909-919 |
| 4500011 | CIF | C38 H30 N4 O4 | C 1 2/c 1 | 29.191; 4.962; 20.316 90; 92.105; 90 | 2941 | Scott G. Fleischman; Srinivasan S. Kuduva; Jennifer A. McMahon; Brian Moulton; Rosa D. Bailey Walsh; Naír Rodríguez-Hornedo; Michael J. Zaworotko Crystal Engineering of the Composition of Pharmaceutical Phases: Multiple-Component Crystalline Solids Involving Carbamazepine Crystal Growth & Design, 2003, 3, 909-919 |
Back to the search form
Your own data is not in the COD? Deposit it, thanks!